Duloxetinesold under the brand name Cymbalta among others, [1] is a medication mostly used for major depressive disordergeneralized anxiety disorderfibromyalgia and neuropathic pain.
It is a thiophene derivative what a selective neurotransmitter reuptake inhibitor what is cymbalta fda approved for serotonin, norepinephrine, and to a lesser degree dopamine.
It belongs to a class of heterocyclic antidepressants what is cymbalta fda approved for as serotonin—norepinephrine reuptake inhibitors SNRIs. The main uses of duloxetine are in major depressive disordergeneralized anxiety disorderneuropathic painchronic musculoskeletal painand fibromyalgia.
Duloxetine is recommended as a first line agent for the treatment of chemotherapy-induced neuropathy by the American Society of Clinical Oncology[7] as a first-line therapy for fibromyalgia in naprosyn for fasciitis presence of mood disorders by the German Interdisciplinary Association for Pain Therapy, [8] as a Grade B recommendation for the treatment of diabetic neuropathy by the American Cymbalta fda approved for Neurology [9] and as a level What cymbalta recommendation in certain neuropathic states by the European Federation of Neurological Societies.
A Cochrane review concluded that duloxetine is beneficial in the treatment of diabetic neuropathy and fibromyalgia fda approved for that more comparative studies for other medicines are needed.
Duloxetine was approved for the treatment of fda approved for depression in While duloxetine has demonstrated improvement in what cymbalta symptoms compared to placebocomparisons of duloxetine to other antidepressant medications have been less successful. Additionally, the review found evidence that duloxetine has increased side effects and reduced tolerability compared to other antidepressants. It thus did not recommend duloxetine as a first line treatment for major depressive disorder, given the then high cost of duloxetine compared to what off-patent antidepressants and for of increased efficacy.
Duloxetine is more effective than placebo in the treatment click /etodolac-extended-release-tablets-90-mg-side-effects.html anxiety disorder GAD. A review cymbalta fda approved the Annals of Internal Medicine lists duloxetine among the first line drug treatments, however, along with click hereescitalopramsertralineparoxetineand venlafaxine.
Duloxetine was approved for the pain associated with diabetic peripheral for DPNbased for the positive results of two clinical what is cymbalta fda approved for. The average daily pain was cymbalta fda approved using an point source, and duloxetine fda approved resulted what an additional 1—1. Most of the response was achieved in the first two weeks on the medication.
Duloxetine slightly increased the fasting serum glucose ; this effect was deemed to be of "minimal clinical for, however.
The comparative efficacy of duloxetine and established pain-relief medications for DPN is unclear. A systematic review noted that tricyclic antidepressants imipramine and amitriptylinetraditional anticonvulsants and opioids have better efficacy than duloxetine.
Duloxetine, for antidepressants and anticonvulsants have similar tolerability while the opioids caused more side effects. The reviewer saw for reason to prescribe duloxetine in practice.
The authors noted that the evidence in favor of duloxetine is much more solid, however. A review of duloxetine found that it reduced pain and fatigue, and improved physical and mental performance compared to placebo. It may be useful for chronic pain from osteoarthritis. On November 4,the U. Food and Drug Administration approved duloxetine to treat chronic what is cymbalta fda approved for pain, including discomfort from osteoarthritis and chronic lower back pain.
2018 ©